{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:43:32Z","timestamp":1790707412087,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.prro.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:01:22Z","timestamp":1740639682000},"page":"367-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline"],"prefix":"10.1016","volume":"15","author":[{"given":"Mary","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Almada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Aranha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dorth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma B.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan R.","family":"Jethwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Kachnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqi","family":"Pollom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence T.","family":"Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horatio","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0130-094X","authenticated-orcid":false,"given":"Amanda R.","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Czito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.02.001_bib0001","series-title":"Clinical Practice Guidelines We Can Trust","article-title":"Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"10.1016\/j.prro.2025.02.001_bib0002","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","article-title":"Committee on Standards for Systematic Reviews of Comparative Effectiveness Research","year":"2011"},{"key":"10.1016\/j.prro.2025.02.001_bib0003","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015","volume":"112","author":"Deshmukh","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2025.02.001_bib0004","unstructured":"Cancer Stat Facts: Anal Cancer. National Cancer Institute. Published 2023. Accessed March 29, 2024. https:\/\/seer.cancer.gov\/statfacts\/html\/anus.html"},{"key":"10.1016\/j.prro.2025.02.001_bib0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1071\/SH12070","article-title":"The epidemiology of anal cancer","volume":"9","author":"Grulich","year":"2012","journal-title":"Sex Health"},{"key":"10.1016\/j.prro.2025.02.001_bib0006","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.2017.74.9291","article-title":"Anal cancer risk among people with HIV infection in the United States","volume":"36","author":"Colon-Lopez","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0007","first-page":"1049","article-title":"UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.02.001_bib0008","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0009","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0010","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0011","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0012","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: Final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0013","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.prro.2025.02.001_bib0014","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2025.02.001_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2021.08.008","article-title":"Long-term outcomes of NRG Oncology\/RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in anal canal cancer","volume":"112","author":"Kachnic","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0016","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnci\/djae195","article-title":"Treatment of stages I-III squamous cell anal cancer: A comparative effectiveness systematic review","volume":"117","author":"Troester","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2025.02.001_bib0017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO-24-02120","article-title":"Systemic therapy for stage I-III anal squamous cell carcinoma: ASCO Guideline","volume":"43","author":"Morris","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0018","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","article-title":"Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0019","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ijrobp.2018.04.033","article-title":"Toxicity, tolerability, and compliance of concurrent capecitabine or 5-fluorouracil in radical management of anal cancer with single-dose mitomycin-c and intensity modulated radiation therapy: Evaluation of a national cohort","volume":"101","author":"Jones","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2017.03.022","article-title":"Capecitabine with mitomycin reduces acute hematologic toxicity and treatment delays in patients undergoing definitive chemoradiation using intensity modulated radiation therapy for anal cancer","volume":"98","author":"Goodman","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0021","doi-asserted-by":"crossref","first-page":"665","DOI":"10.21037\/jgo.2016.06.04","article-title":"A comparison between 5-fluorouracil\/mitomycin and capecitabine\/mitomycin in combination with radiation for anal cancer","volume":"7","author":"Peixoto","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0022","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2017.3151","article-title":"Management of stage I squamous cell carcinoma of the anal canal","volume":"153","author":"Chai","year":"2018","journal-title":"JAMA surgery"},{"key":"10.1016\/j.prro.2025.02.001_bib0023","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.ejso.2020.03.003","article-title":"Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis","volume":"46","author":"Gao","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0024","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/COC.0000000000000339","article-title":"Clinical and economic evaluation of treatment strategies for T1N0 anal canal cancer","volume":"41","author":"Deshmukh","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/0284186X.2018.1442931","article-title":"Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin","volume":"57","author":"Leon","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0026","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM200003163421107","article-title":"Carcinoma of the anal canal","volume":"342","author":"Ryan","year":"2000","journal-title":"New Eng J Med"},{"key":"10.1016\/j.prro.2025.02.001_bib0027","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: A preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2025.02.001_bib0028","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: A pooled data analysis of radiation therapy oncology group trials 87-04 and 98-11","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0029","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jgo.2022.04.002","article-title":"Anal cancer in older adults: A Young International Society of Geriatric Oncology review paper","volume":"13","author":"Martinez-Cannon","year":"2022","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2010.11.011","article-title":"Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: Are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?","volume":"98","author":"Fraunholz","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/oncolo\/oyab006","article-title":"Definitive intensity-modulated chemoradiation for anal squamous cell carcinoma: Outcomes and toxicity of 428 patients treated at a single institution","volume":"27","author":"Holliday","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.prro.2025.02.001_bib0032","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: A randomised, multicentre, non-inferiority, phase 3 trial","volume":"13","author":"Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0033","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.prro.2025.02.001_bib0034","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/codi.12951","article-title":"Clinicopathological and virological characteristics of superficially invasive squamous-cell carcinoma of the anus","volume":"17","author":"Arana","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.prro.2025.02.001_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2013.03.012","article-title":"Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: A propensity score analysis","volume":"107","author":"Dasgupta","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0036","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.adro.2017.04.007","article-title":"Quantitative FDG-PET\/CT predicts local recurrence and survival for squamous cell carcinoma of the anus","volume":"2","author":"Cardenas","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0037","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4149\/neo_2020_191229N1350","article-title":"Improved survival in patients with FDG-PET\/CT-based radiotherapy treatment planning for squamous cell anal cancer","volume":"67","author":"Lohynska","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.prro.2025.02.001_bib0038","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1038\/s41598-022-08525-1","article-title":"Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer","volume":"12","author":"Sauter","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.prro.2025.02.001_bib0039","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00066-023-02056-y","article-title":"Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma","volume":"199","author":"Untiedt","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2025.02.001_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2017.01.006","article-title":"The Impact of intensity modulated radiation therapy on hospitalization outcomes in the SEER-medicare population with anal squamous cell carcinoma","volume":"98","author":"Pollom","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109542","article-title":"Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE","volume":"183","author":"Vendrely","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0042","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2018.05.044","article-title":"Intensity modulated radiation therapy versus conventional radiation for anal cancer in the veterans affairs system","volume":"102","author":"Bryant","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0043","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1002\/cncr.31721","article-title":"Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study","volume":"124","author":"Elson","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2025.02.001_bib0044","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5114\/jcb.2019.82804","article-title":"Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis","volume":"11","author":"Arcelli","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.prro.2025.02.001_bib0046","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.brachy.2016.08.003","article-title":"Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results","volume":"15","author":"Gryc","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2025.02.001_bib0047","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2018.08.008","article-title":"Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03)","volume":"129","author":"Faivre","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0048","first-page":"776","article-title":"What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort","volume":"53","author":"Bacci","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.prro.2025.02.001_bib0049","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2013.03.008","article-title":"Elective inguinal node irradiation in early-stage T2N0 anal cancer: Prognostic impact on locoregional control","volume":"87","author":"Zilli","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0050","article-title":"Multi-institutional comparison of intensity modulated photon versus proton radiation therapy in the management of squamous cell carcinoma of the anus","volume":"6","author":"Mohiuddin","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0051","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijrobp.2019.04.040","article-title":"Pencil beam scanning proton beam chemoradiation therapy with 5-fluorouracil and mitomycin-C for definitive treatment of carcinoma of the anal canal: A multi-institutional pilot feasibility study","volume":"105","author":"Wo","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0052","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2019.10.016","article-title":"Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma","volume":"106","author":"Shakir","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0053","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.ijrobp.2011.02.010","article-title":"Anal canal cancer: Management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)","volume":"82","author":"Ortholan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0054","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.annonc.2020.06.012","article-title":"Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: Results of a post hoc analysis from the randomised phase III ACT II trial","volume":"31","author":"Glynne-Jones","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0055","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1200\/JCO.2011.36.1790","article-title":"Cause-specific colostomy rates after radiotherapy for anal cancer: A Danish multicentre cohort study","volume":"29","author":"Sunesen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0056","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12029-024-01019-5","article-title":"Simultaneous integrated boost (SIB) versus sequential boost in anal cancer patients: A single-center experience","volume":"55","author":"Khosla","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.prro.2025.02.001_bib0057","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00384-023-04411-y","article-title":"Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy","volume":"38","author":"Rotondi","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.prro.2025.02.001_bib0058","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13014-018-1124-9","article-title":"Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: Results of a retrospective observational study","volume":"13","author":"Franco","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0059","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/0284186X.2015.1124141","article-title":"Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal","volume":"55","author":"Tomasoa","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1120\/jacmp.v17i5.6123","article-title":"Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer","volume":"17","author":"Feng","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0061","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00066-015-0888-1","article-title":"Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas","volume":"191","author":"Farzin","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2025.02.001_bib0062","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-015-0913-4","article-title":"Comparative treatment planning study on sequential vs. simultaneous integrated boost in head and neck cancer patients: Differences in dose distributions and potential implications for clinical practice","volume":"192","author":"Stromberger","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2025.02.001_bib0063","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejmp.2020.04.012","article-title":"Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer","volume":"73","author":"Sukhikh","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.prro.2025.02.001_bib0064","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2010.10.005","article-title":"T1-2 anal carcinoma requires elective inguinal radiation treatment\u2013the results of Trans Tasman Radiation Oncology Group study TROG 99.02","volume":"98","author":"Matthews","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13014-020-01567-7","article-title":"Patterns of recurrence in anal cancer: A detailed analysis","volume":"15","author":"Nilsson","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0066","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/CCO.0b013e32816f76de","article-title":"Current treatment for localized anal carcinoma","volume":"19","author":"Das","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0067","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.radonc.2012.03.007","article-title":"Clinical target volumes in anal cancer: Calculating what dose was likely to have been delivered in the UK ACT II trial protocol","volume":"103","author":"Aggarwal","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0068","doi-asserted-by":"crossref","first-page":"277","DOI":"10.21037\/jgo.2020.02.09","article-title":"Impact of radiotherapy duration on overall survival in squamous cell carcinoma of the anus","volume":"11","author":"Mehta","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0069","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaoncol.2020.0809","article-title":"Factors associated with chemoradiation therapy interruption and noncompletion among patients with squamous cell anal carcinoma","volume":"6","author":"Raphael","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/0284186X.2015.1043396","article-title":"Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma","volume":"55","author":"Julie","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0071","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijrobp.2016.10.010","article-title":"Hematologic nadirs during chemoradiation for anal cancer: Temporal characterization and dosimetric predictors","volume":"97","author":"Lee","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0072","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ijrobp.2011.12.072","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal","volume":"84","author":"Bazan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0073","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.prro.2017.03.008","article-title":"Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation","volume":"7","author":"Rose","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0074","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2017.02.005","article-title":"Predictors of radiation therapy-related gastrointestinal toxicity from anal cancer dose-painted intensity modulated radiation therapy: Secondary analysis of NRG oncology RTOG 0529","volume":"98","author":"Olsen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0075","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.clon.2021.09.011","article-title":"Dosimetric and clinical predictors for acute and late gastrointestinal toxicity following chemoradiotherapy of locally advanced anal cancer","volume":"34","author":"Nilsson","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2025.02.001_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.11.018","article-title":"Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer","volume":"178","author":"Lukovic","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0077","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2022.05.009","article-title":"Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity modulated radiation therapy and concurrent chemotherapy","volume":"114","author":"De","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0078","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clon.2016.10.005","article-title":"Initial results from the Royal College of Radiologists' UK national audit of anal cancer radiotherapy 2015","volume":"29","author":"Muirhead","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0079","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.294.20.2587","article-title":"Risk of pelvic fractures in older women following pelvic irradiation","volume":"294","author":"Baxter","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2025.02.001_bib0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2015.02.029","article-title":"Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0081","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2013.06.2044","article-title":"Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: Results of the BC2001 trial (CRUK\/01\/004)","volume":"87","author":"Huddart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0082","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clon.2014.09.016","article-title":"Defining bowel dose volume constraints for bladder radiotherapy treatment planning","volume":"27","author":"McDonald","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2025.02.001_bib0083","article-title":"Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): Radiotherapy planning and delivery guidance","volume":"10","author":"Hafeez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.prro.2025.02.001_bib0084","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.prro.2023.10.002","article-title":"Daily vaginal dilator use during radiation for women with squamous cell carcinoma of the anus: Vaginal wall dosimetry and patient-reported sexual function","volume":"14","author":"Arzola","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.prro.2022.01.015","article-title":"ECOG-ACRIN guideline for contouring and treatment of early stage anal cancer using IMRT\/IGRT","volume":"12","author":"Damico","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0086","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2015.12.006","article-title":"Irradiation of FDG-PET-defined active bone marrow subregions and acute hematologic toxicity in anal cancer patients undergoing chemoradiation","volume":"94","author":"Rose","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0087","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.prro.2014.09.003","article-title":"Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer","volume":"5","author":"Mirabeau-Beale","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0088","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.prro.2019.07.001","article-title":"Literature review of vaginal stenosis and dilator use in radiation oncology","volume":"9","author":"Damast","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0089","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0360-3016(94)00426-L","article-title":"Late injury of cancer therapy on the female reproductive tract","volume":"31","author":"Grigsby","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2014.05.008","article-title":"Quality of life (QOL) in women treated for gynecologic malignancies with radiation therapy: A literature review of patient-reported outcomes","volume":"134","author":"Mirabeau-Beale","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0091","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2015.06.018","article-title":"Prospective study of vaginal dilator use adherence and efficacy following radiotherapy","volume":"116","author":"Law","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0092","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/IGC.0000000000000253","article-title":"Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method","volume":"24","author":"Bakker","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2025.02.001_bib0093","unstructured":"Miles T, Bergmark K, Bruner DW, et al. International guidelines on vaginal dilation after pelvic radiotherapy. Owen Mumford Ltd, 2012. Accessed July 8, 2024.https:\/\/www.pocd.com.au\/core\/media\/media.nl\/id.47537\/c.3923593\/.f?h=f2e5bc493442741b7e6c&srsltid=AfmBOoqQrddpcrIlZdWY0ZOqtlqVwOzzIwlPxmDNOVYOxmG26zcaR5lI"},{"key":"10.1016\/j.prro.2025.02.001_bib0094","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.prro.2017.02.003","article-title":"Perceptions and practices regarding women's vaginal health following radiation therapy: A survey of radiation oncologists practicing in the United States","volume":"7","author":"Kachnic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0095","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/DCR.0000000000002600","article-title":"Assessment of patient-reported outcomes in patients with anal squamous-cell cancer undergoing combined modality therapy","volume":"65","author":"Taylor","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2025.02.001_bib0096","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/j.prro.2022.05.006","article-title":"Patient-reported sexual function in long-term survivors of anal cancer treated with definitive intensity modulated radiation therapy and concurrent chemotherapy","volume":"12","author":"Corrigan","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0097","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jsxm.2021.05.015","article-title":"Quality of life and sexual function of men who have sex with men treated for anal cancer: A prospective trial of a neglected population","volume":"18","author":"Mauro","year":"2021","journal-title":"J Sex Med"},{"key":"10.1016\/j.prro.2025.02.001_bib0098","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2008.10.011","article-title":"Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer","volume":"74","author":"Yau","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0099","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijrobp.2007.10.043","article-title":"Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH","volume":"70","author":"Bruheim","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.02.001_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): A post-hoc analysis of randomised controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2019.03.014","article-title":"Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma","volume":"136","author":"Duimering","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246535","article-title":"Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer","volume":"16","author":"Susko","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.prro.2025.02.001_bib0103","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.prro.2016.01.004","article-title":"Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma","volume":"6","author":"Goldman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0104","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1007\/s00330-022-08648-z","article-title":"Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy","volume":"32","author":"Adusumilli","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.prro.2025.02.001_bib0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/COC.0000000000000673","article-title":"Determining optimal follow-up for patients with anal cancer following chemoradiation","volume":"43","author":"Frazer","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2025.02.001_bib0106","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/DCR.0000000000001750","article-title":"High-resolution anoscopy surveillance after anal squamous cell carcinoma: High-grade squamous intraepithelial lesion detection and treatment may influence local recurrence","volume":"63","author":"Cappello","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2025.02.001_bib0107","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/DCR.0000000000000291","article-title":"Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer?","volume":"58","author":"Peterson","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prro.2025.02.001_bib0108","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00330-016-4337-z","article-title":"The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer","volume":"27","author":"Kochhar","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.prro.2025.02.001_bib0109","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/ijms25074005","article-title":"Assessing circulating tumour DNA (ctDNA) as a biomarker for anal cancer management: A systematic review","volume":"25","author":"Temperley","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:24:14Z","timestamp":1762561454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850025000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1879850025000207"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.02.001","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}